Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013 A Retrospective Study

被引:47
作者
Si, Wen [1 ,2 ]
Li, Ying [1 ,3 ]
Han, Yingjie [1 ,2 ]
Zhang, Fan [1 ]
Wang, Yingzhe [1 ]
Li, Ying [1 ,3 ]
Linghu, Rui Xia [1 ]
Zhang, Xingyang [1 ]
Yang, Junlan [1 ]
机构
[1] Chinese Peoples Liberat Army PLAGH, Gen Hosp, Dept Med Oncol 1, Beijing 100853, Peoples R China
[2] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China
[3] Beijing Geriatr Hosp, Beijing, Peoples R China
关键词
INTERNATIONAL EXPERT CONSENSUS; HORMONE-RECEPTOR STATUS; PRIMARY THERAPY; WOMEN; SURVIVAL; AGE; HIGHLIGHTS; MANAGEMENT; MORTALITY; RACE;
D O I
10.1097/MD.0000000000000820
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
This study aimed to summarize the epidemiological and pathological trends of breast cancer in Chinese women. The clinical data of 4968 breast cancer patients treated at the Chinese PLA General Hospital from 1993 to 2013 were retrospectively reviewed. The mean +/- standard deviation (SD) age was 47.4 +/- 11.3 years before the year 2001, 49.2 +/- 11.2 years during 2001 to 2010, and 50.6 +/- 11.4 years after the year 2010, respectively (P < 0.001). The ratio of premenopausal women to postmenopausal women was 1.6 and no significant changes were found during the period (P = 0.121). The proportion of patients with Scarff Bloom Richardson III breast cancer showed significant increase along with time (P = 0.015). The breast cancer was accounting for 31.7% at stage I and DCIS/LCIS and tend to be diagnosed with early stage around time (P < 0.001). The proportion of DCIS/LCIS and stage I increased with time during the 20 years from 14.6% to 33.2%, whereas the proportion of stage III to IV decreased. The proportion of Luminal A-like subtype gradually reduced and Luminal B-like (HER2-negative) increased and developed to the predominant type. Older age and earlier stage at diagnosis, as well as the alternation of predominant molecular subtypes, have become the developed trends of breast cancer.
引用
收藏
页数:7
相关论文
共 41 条
[1]
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives [J].
Ades, Felipe ;
Zardavas, Dimitrios ;
Bozovic-Spasojevic, Ivana ;
Pugliano, Lina ;
Fumagalli, Debora ;
de Azambuja, Evandro ;
Viale, Giuseppe ;
Sotiriou, Christos ;
Piccart, Martine .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2794-+
[2]
Prognostic value of morphology and hormone receptor status in breast cancer -: a population-based study [J].
Allemani, C ;
Sant, M ;
Berrino, F ;
Aareleid, T ;
Chaplain, G ;
Coebergh, JW ;
Colonna, M ;
Contiero, P ;
Danzon, A ;
Federico, M ;
Gafà, L ;
Grosclaude, P ;
Hédelin, G ;
Macè-Lesech, J ;
Garcia, CM ;
Paci, E ;
Raverdy, N ;
Tretarre, B ;
Williams, EMI .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1263-1268
[3]
[Anonymous], 2012, SEER Cancer Statistics Review, 1975-2009 Vintage 2009 Populations
[4]
[Anonymous], CHIN J BREAST DIS
[5]
Badar F, 2011, ASIAN PAC J CANCER P, V12, P827
[6]
Bhikoo Riyaz, 2011, Cancers (Basel), V3, P2382, DOI 10.3390/cancers3022382
[7]
Report of Incidence and Mortality in China Cancer Registries, 2008 [J].
Chen, Wan-qing ;
Zheng, Rong-shou ;
Zhang, Si-wei ;
Li, Ni ;
Zhao, Ping ;
Li, Guang-lin ;
Wu, Liang-you ;
He, Jie .
CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (03) :171-180
[8]
The incidences and mortalities of major cancers in China, 2009 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Zhang, Siwei ;
Zhao, Ping ;
Li, Guanglin ;
Wu, Lingyou ;
He, Jie .
CHINESE JOURNAL OF CANCER, 2013, 32 (03) :106-112
[9]
Edge S.B., 2010, AJCC cancer staging manual, V649
[10]
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience [J].
Elkum, Naser ;
Dermime, Said ;
Ajarim, Dahish ;
Al-Zahrani, Ali ;
Alsayed, Adher ;
Tulbah, Asma ;
Al Malik, Osama ;
Alshabanah, Mohamed ;
Ezzat, Adnan ;
Al-Tweigeri, Taher .
BMC CANCER, 2007, 7 (1)